FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Guidance on Bioequivalence Studies During Covid Emergency

FDA releases a new guidance entitled Protecting Participants in Bioequivalence Studies for Abbreviated New Drug Applications During the Covid-19 Publi...

Federal Register

Survey of Drug Product Manufacturing Quality

Federal Register notice: FDA sends to OMB an information collection entitled Survey of Drug Product Manufacturing, Processing, and Packing Facilities ...

Human Drugs

FDA-483 Posted on BMS Liso-cel Pre-approval Inspection

An FDA inspection at Lonzas Viral Vector contract-manufacturing facility leads to a four-item FDA-483 and resumption of the agencys review of a Bristo...

Human Drugs

Safety Alert on Preparing Vinca Alkaloids

FDA alerts health care professionals about labeling updates for the preparation of vinca alkaloids, a group of chemotherapy agents, to warn about intr...

FDA General

David Kessler Taking Over Covid-19 Vaccine Response

The incoming Biden Administration chooses former FDA commissioner David Kessler stration to lead the U.S. Covid-19 vaccination efforts replacing Oper...

FDA General

FDA WEBVIEW CLOSED FOR MLK DAY

FDA Webviews newsroom closes Monday (1/18) in observance of Martin Luther King day.

Medical Devices

Indictment on Scheme to Steal Medical Devices for Resale

FDA announces an indictment (XXX DELETE XXX)charging two former Michigan-based Beaumont Hospital employees and a medical supply distributor with wire ...

Human Drugs

Orange Book Modernization Act Codifies Current Practices: Analysis

Two Hyman Phelps attorneys analyze provisions of the Orange Book Modernization Act signed into law earlier this month.

Medical Devices

Covid-19 Coagulation Systems Guidance

FDA issues a pandemic guidance easing enforcement against some modifications to coagulation systems.

Federal Register

FDA Withdrawing 27 No-longer-marketed ANDAs

Federal Register notice: FDA withdraws approval of 27 ANDAs from multiple applicants because the products are no longer marketed.